Global and United States Biopharmaceutical CMO Services Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Biopharmaceutical CMO Services Market
This report focuses on global and United States Biopharmaceutical CMO Services market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Biopharmaceutical CMO Services market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Biologics Manufacturing accounting for % of the Biopharmaceutical CMO Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Clinical Manufacturing was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Biopharmaceutical CMO Services market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Biopharmaceutical CMO Services Scope and Market Size
Biopharmaceutical CMO Services market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical CMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Biopharmaceutical CMO Services market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Segment by Application
Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma

Frequently Asked Questions